Completed
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
NCT00976820
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- GSK Investigational Site Conway, Arkansas, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site San Francisco, California, United States